Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.

Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, Milev R, Harkness KL, Frey BN, Lam RW, Strother SC, Rotzinger S, Kennedy SH, MacQueen GM.

Neuropsychopharmacology. 2019 Oct 14. doi: 10.1038/s41386-019-0542-1. [Epub ahead of print]

PMID:
31610545
2.

The Chronotherapeutic Treatment of Bipolar Disorders: A Systematic Review and Practice Recommendations from the ISBD Task Force on Chronotherapy and Chronobiology.

Gottlieb JF, Benedetti F, Geoffroy PA, Henriksen TEG, Lam RW, Murray G, Phelps J, Sit D, Swartz HA, Crowe M, Etain B, Frank E, Goel N, Haarman BCM', Inder M, Kallestad H, Kim SJ, Martiny K, Meesters Y, Porter R, Riemersma-van der Lek RF, Ritter PS, Schulte PFJ, Scott J, Wu JC, Yu X, Chen S.

Bipolar Disord. 2019 Oct 14. doi: 10.1111/bdi.12847. [Epub ahead of print] Review.

PMID:
31609530
3.

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.

Ju C, Fiori LM, Belzeaux R, Theroux JF, Chen GG, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, Rotzinger S, Soares CN, Uher R, Li Q, Foster JA, Kennedy SH, Turecki G.

Transl Psychiatry. 2019 Oct 8;9(1):254. doi: 10.1038/s41398-019-0589-0.

4.

Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.

Chakrabarty T, Harkness KL, McInerney SJ, Quilty LC, Milev RV, Kennedy SH, Frey BN, MacQueen GM, Müller DJ, Rotzinger S, Uher R, Lam RW.

Psychol Med. 2019 Oct 4:1-12. doi: 10.1017/S003329171900268X. [Epub ahead of print]

PMID:
31583989
5.

White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study.

Davis AD, Hassel S, Arnott SR, Harris J, Lam RW, Milev R, Rotzinger S, Zamyadi M, Frey BN, Minuzzi L, Strother SC, MacQueen GM, Kennedy SH, Hall GB.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Oct;4(10):913-924. doi: 10.1016/j.bpsc.2019.05.016. Epub 2019 Jun 12.

PMID:
31471185
6.

Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force.

Passos IC, Ballester PL, Barros RC, Librenza-Garcia D, Mwangi B, Birmaher B, Brietzke E, Hajek T, Lopez Jaramillo C, Mansur RB, Alda M, Haarman BCM, Isometsa E, Lam RW, McIntyre RS, Minuzzi L, Kessing LV, Yatham LN, Duffy A, Kapczinski F.

Bipolar Disord. 2019 Aug 29. doi: 10.1111/bdi.12828. [Epub ahead of print] Review.

PMID:
31465619
7.

Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study.

Alders GL, Davis AD, MacQueen G, Strother SC, Hassel S, Zamyadi M, Sharma GB, Arnott SR, Downar J, Harris JK, Lam RW, Milev R, Müller DJ, Ravindran A, Kennedy SH, Frey BN, Minuzzi L, Hall GB; CAN-BIND Investigator Team.

J Affect Disord. 2019 Oct 1;257:765-773. doi: 10.1016/j.jad.2019.07.037. Epub 2019 Jul 6.

PMID:
31400735
8.

Methodological approaches to situational analysis in global mental health: a scoping review.

Murphy JK, Michalak EE, Colquhoun H, Woo C, Ng CH, Parikh SV, Culpepper L, Dewa CS, Greenshaw AJ, He Y, Kennedy SH, Li XM, Liu T, Soares CN, Wang Z, Xu Y, Chen J, Lam RW.

Glob Ment Health (Camb). 2019 Jun 13;6:e11. doi: 10.1017/gmh.2019.9. eCollection 2019. Review.

9.

Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment.

Belzeaux R, Fiori LM, Lopez JP, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, Rotzinger S, Soares CN, Uher R, Foster JA, Kennedy SH, Turecki G.

J Clin Psychiatry. 2019 May 7;80(3). pii: 18m12556. doi: 10.4088/JCP.18m12556.

PMID:
31087825
10.

Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants.

Nogovitsyn N, Souza R, Muller M, Srajer A, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Bray SL, Lebel C, Addington JM, Milev R, Harkness KL, Frey BN, Lam RW, Strother SC, Goldstein BI, Rotzinger S, Kennedy SH, MacQueen GM.

Neuroimage. 2019 Aug 15;197:589-597. doi: 10.1016/j.neuroimage.2019.05.017. Epub 2019 May 7.

PMID:
31075395
11.

Functional disconnectivity of the hippocampal network and neural correlates of memory impairment in treatment-resistant depression.

Ge R, Torres I, Brown JJ, Gregory E, McLellan E, Downar JH, Blumberger DM, Daskalakis ZJ, Lam RW, Vila-Rodriguez F.

J Affect Disord. 2019 Jun 15;253:248-256. doi: 10.1016/j.jad.2019.04.096. Epub 2019 Apr 29.

PMID:
31060011
12.

Locating the Site of Neuropathic Pain In Vivo Using MMP-12-Targeted Magnetic Nanoparticles.

Husain SF, Lam RWM, Hu T, Ng MWF, Liau ZQG, Nagata K, Khanna S, Lam Y, Bhakoo K, Ho RCM, Wong HK.

Pain Res Manag. 2019 Mar 6;2019:9394715. doi: 10.1155/2019/9394715. eCollection 2019.

13.

Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.

Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, Leri F, McInerney S, MacQueen GM, Minuzzi L, Müller DJ, Parikh SV, Placenza FM, Quilty LC, Ravindran AV, Sassi RB, Soares CN, Strother SC, Turecki G, Vaccarino AL, Vila-Rodriguez F, Yu J, Uher R; CAN-BIND Investigator Team.

J Clin Psychiatry. 2019 Feb 5;80(2). pii: 18m12202. doi: 10.4088/JCP.18m12202.

PMID:
30840787
14.

The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

MacQueen GM, Hassel S, Arnott SR, Jean A, Bowie CR, Bray SL, Davis AD, Downar J, Foster JA, Frey BN, Goldstein BI, Hall GB, Harkness KL, Harris J, Lam RW, Lebel C, Milev R, Müller DJ, Parikh SV, Rizvi S, Rotzinger S, Sharma GB, Soares CN, Turecki G, Vila-Rodriguez F, Yu J, Zamyadi M, Strother SC, Kennedy SH; CAN-BIND Investigator Team.

J Psychiatry Neurosci. 2019 Jul 1;44(4):223-236.

15.

Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.

Valdes M, Bertolin S, Qian H, Wong H, Lam RW, Yatham LN.

J Affect Disord. 2019 Mar 1;246:861-866. doi: 10.1016/j.jad.2019.01.003. Epub 2019 Jan 5.

PMID:
30795492
16.

Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.

Kaster TS, Downar J, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Blumberger DM.

Am J Psychiatry. 2019 May 1;176(5):367-375. doi: 10.1176/appi.ajp.2018.18091096. Epub 2019 Feb 15.

PMID:
30764649
17.

Structural network integrity of the central executive network is associated with the therapeutic effect of rTMS in treatment resistant depression.

Ge R, Downar J, Blumberger DM, Daskalakis ZJ, Lam RW, Vila-Rodriguez F.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:217-225. doi: 10.1016/j.pnpbp.2019.01.012. Epub 2019 Jan 25.

PMID:
30685322
18.

Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine.

Alonso-Prieto E, Rubino C, Lucey M, Evans VC, Tam EM, Woo C, Iverson GL, Chakrabarty T, Yatham LN, Lam RW.

Psychiatry Res. 2019 Feb;272:144-148. doi: 10.1016/j.psychres.2018.12.062. Epub 2018 Dec 10.

PMID:
30583256
19.

Inclusion of mental health in global economic development.

Ng CH, Goodenow MM, Greenshaw AJ, Upshall P, Lam RW.

BJPsych Int. 2018 Nov;15(4):74-76. doi: 10.1192/bji.2017.23.

20.

Discrepancy between objective and subjective cognition in major depressive disorder.

Serra-Blasco M, Torres IJ, Vicent-Gil M, Goldberg X, Navarra-Ventura G, Aguilar E, Via E, Portella MJ, Figuereo I, Palao D, Lam RW, Cardoner N.

Eur Neuropsychopharmacol. 2019 Jan;29(1):46-56. doi: 10.1016/j.euroneuro.2018.11.1104. Epub 2018 Nov 28.

PMID:
30503099
21.

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder.

Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D.

Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-2877. doi: 10.2147/NDT.S175188. eCollection 2018.

22.

Non-linear Entropy Analysis in EEG to Predict Treatment Response to Repetitive Transcranial Magnetic Stimulation in Depression.

Shalbaf R, Brenner C, Pang C, Blumberger DM, Downar J, Daskalakis ZJ, Tham J, Lam RW, Farzan F, Vila-Rodriguez F.

Front Pharmacol. 2018 Oct 30;9:1188. doi: 10.3389/fphar.2018.01188. eCollection 2018.

23.

Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study.

Bond DJ, Su W, Honer WG, Dhanoa T, Batres-Y-Carr T, Lee SS, Torres IJ, Lam RW, Yatham LN.

Bipolar Disord. 2019 Feb;21(1):50-60. doi: 10.1111/bdi.12722. Epub 2018 Dec 1.

PMID:
30422375
24.

Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project.

Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, Duffy A, Alda M, Calkin C, Sharma V, Anand A, Singh MK, Hajek T, Boyce P, Frey BN, Castle DJ, Young AH, Vieta E, Rybakowski JK, Swartz HA, Schaffer A, Murray G, Bayes A, Lam RW, Bora E, Post RM, Ostacher MJ, Lafer B, Cleare AJ, Burdick KE, O'Donovan C, Ortiz A, Henry C, Kanba S, Rosenblat JD, Parikh SV, Bond DJ, Grunebaum MF, Frangou S, Goldberg JF, Orum M, Osser DN, Frye MA, McIntyre RS, Fagiolini A, Manicavasagar V, Carlson GA, Malhi GS.

Aust N Z J Psychiatry. 2018 Oct 31:4867418808382. doi: 10.1177/0004867418808382. [Epub ahead of print]

PMID:
30378461
25.

Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report.

Allen TA, Lam RW, Milev R, Rizvi SJ, Frey BN, MacQueen GM, Müller DJ, Uher R, Kennedy SH, Quilty LC.

Psychol Med. 2019 Jul;49(10):1629-1638. doi: 10.1017/S0033291718002441. Epub 2018 Sep 17.

PMID:
30220263
26.

Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression.

Benedetti F, Avery DH, Bauer M, Bunney WE, Çaliyurt O, Camardese G, Colombo C, Dallaspezia S, Henriksen TE, Kasper S, Kuriyama K, Lam RW, Martiny K, Meesters Y, Mishima K, Schulte R, Suzuki M, Święcicki Ł, Uchiyama M, Veale D, Winkler D, Wu J, Kupeli NY, Yoshiike T, Yu X.

Am J Psychiatry. 2018 Sep 1;175(9):905-906. doi: 10.1176/appi.ajp.2018.18020231. No abstract available.

PMID:
30173556
27.

Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.

Harrison JE, Barry H, Baune BT, Best MW, Bowie CR, Cha DS, Culpepper L, Fossati P, Greer TL, Harmer C, Klag E, Lam RW, Lee Y, Mansur RB, Wittchen HU, McIntyre RS.

Int J Methods Psychiatr Res. 2018 Sep;27(3):e1736. doi: 10.1002/mpr.1736. Epub 2018 Aug 7.

28.

Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression.

Levitan RD, Levitt AJ, Michalak EE, Morehouse R, Ramasubbu R, Yatham LN, Tam EM, Lam RW.

J Clin Psychiatry. 2018 Jul 24;79(4). pii: 17m11856. doi: 10.4088/JCP.17m11856.

PMID:
30063303
29.

The association of duration and severity of disease with executive function: Differences between drug-naïve patients with bipolar and unipolar depression.

Yang T, Zhao G, Mao R, Huang J, Xu X, Su Y, Zhu N, Zhou R, Lin X, Xia W, Wang F, Liu R, Wang X, Huang Z, Wang Y, Hu Y, Cao L, Yuan C, Wang Z, Lam RW, Chen J, Fang Y.

J Affect Disord. 2018 Oct 1;238:412-417. doi: 10.1016/j.jad.2018.05.051. Epub 2018 May 29.

PMID:
29909305
30.

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.

Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J.

Lancet. 2018 Apr 28;391(10131):1683-1692. doi: 10.1016/S0140-6736(18)30295-2. Epub 2018 Apr 26. Erratum in: Lancet. 2018 Jun 23;391(10139):e24.

PMID:
29726344
31.

Use of Placebo in Clinical Trials of Psychotropic Medication.

Hasnain M, Rudnick A, Bonnell WS, Remington G, Lam RW.

Can J Psychiatry. 2018 May;63(5):338-341. doi: 10.1177/0706743717752917.

32.

Abnormal Functional Connectivity of Frontopolar Subregions in Treatment-Nonresponsive Major Depressive Disorder.

Fettes PW, Moayedi M, Dunlop K, Mansouri F, Vila-Rodriguez F, Giacobbe P, Davis KD, Lam RW, Kennedy SH, Daskalakis ZJ, Blumberger DM, Downar J.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Apr;3(4):337-347. doi: 10.1016/j.bpsc.2017.12.003. Epub 2017 Dec 27.

33.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M.

Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14.

34.

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management.

Culpepper L, Lam RW, McIntyre RS.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: TK16043PD4C. doi: 10.4088/JCP.TK16043PD4C.

35.

Implications of Cannabis Legalization on Youth and Young Adults.

Tibbo P, Crocker CE, Lam RW, Meyer J, Sareen J, Aitchison KJ.

Can J Psychiatry. 2018 Jan;63(1):65-71. doi: 10.1177/0706743718759031. No abstract available.

36.

Impact of Cognitive Impairment on Functioning in Patients With Depression.

Lam RW.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1430. doi: 10.4088/JCP.tk16043tx1c.

37.

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management.

Culpepper L, Lam RW, McIntyre RS.

J Clin Psychiatry. 2017 Nov/Dec;78(9):1383-1394. doi: 10.4088/JCP.tk16043ah5c. Review.

38.

The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.

Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, Pat McAndrews M, Blier P, Evans K, Foster JA, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Müller DJ, Parikh SV, Rotzinger S, Soares CN, Strother SC, Turecki G, Kennedy SH; CAN-BIND Investigators Team.

J Affect Disord. 2018 Feb;227:542-549. doi: 10.1016/j.jad.2017.10.028. Epub 2017 Nov 3.

PMID:
29169123
39.

A multicomponent intervention for the management of chronic pain in older adults: study protocol for a randomized controlled trial.

Cheng ST, Chan KL, Lam RWL, Mok MHT, Chen PP, Chow YF, Chung JWY, Law ACB, Lee JSW, Leung EMF, Tam CWC.

Trials. 2017 Nov 9;18(1):528. doi: 10.1186/s13063-017-2270-3.

40.

A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR.

Yatham LN, Sossi V, Ding YS, Vafai N, Arumugham SS, Dhanoa T, Lam RW, Bond DJ, Puyat JH.

Int J Neuropsychopharmacol. 2018 Feb 1;21(2):108-113. doi: 10.1093/ijnp/pyx066.

41.

Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.

Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S, Slavin KV, Berman J, McKhann GM, Patil PG, Rittberg BR, Abosch A, Pandurangi AK, Holloway KL, Lam RW, Honey CR, Neimat JS, Henderson JM, DeBattista C, Rothschild AJ, Pilitsis JG, Espinoza RT, Petrides G, Mogilner AY, Matthews K, Peichel D, Gross RE, Hamani C, Lozano AM, Mayberg HS.

Lancet Psychiatry. 2017 Nov;4(11):839-849. doi: 10.1016/S2215-0366(17)30371-1. Epub 2017 Oct 4.

PMID:
28988904
42.

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.

Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, Severus E, Kasper S, Berk M.

World J Biol Psychiatry. 2018 Aug;19(5):330-348. doi: 10.1080/15622975.2017.1379609. Epub 2017 Oct 6. Review. Erratum in: World J Biol Psychiatry. 2018 Aug;19(5):i.

PMID:
28984491
43.

Quality of life in bipolar disorder: towards a dynamic understanding.

Morton E, Murray G, Michalak EE, Lam RW, Beaulieu S, Sharma V, Cervantes P, Parikh SV, Yatham LN.

Psychol Med. 2018 May;48(7):1111-1118. doi: 10.1017/S0033291717002495. Epub 2017 Sep 18.

PMID:
28918761
44.

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

McIntyre RS, Best MW, Bowie CR, Carmona NE, Cha DS, Lee Y, Subramaniapillai M, Mansur RB, Barry H, Baune BT, Culpepper L, Fossati P, Greer TL, Harmer C, Klag E, Lam RW, Wittchen HU, Harrison J.

J Clin Psychiatry. 2017 Jul;78(7):873-881. doi: 10.4088/JCP.16m11329.

PMID:
28858441
45.

Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression.

Farzan F, Atluri S, Frehlich M, Dhami P, Kleffner K, Price R, Lam RW, Frey BN, Milev R, Ravindran A, McAndrews MP, Wong W, Blumberger D, Daskalakis ZJ, Vila-Rodriguez F, Alonso E, Brenner CA, Liotti M, Dharsee M, Arnott SR, Evans KR, Rotzinger S, Kennedy SH.

Sci Rep. 2017 Aug 7;7(1):7473. doi: 10.1038/s41598-017-07613-x.

46.

The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine.

Sarfati D, Evans VC, Tam EM, Woo C, Iverson GL, Yatham LN, Lam RW.

Int Clin Psychopharmacol. 2017 Nov;32(6):343-349. doi: 10.1097/YIC.0000000000000192.

PMID:
28763344
47.

A sparse representation-based method for parcellation of the resting brain and its application to treatment-resistant major depressive disorder.

Ge R, Blumberger DM, Downar J, Daskalakis ZJ, Tham JCW, Lam RW, Vila-Rodriguez F.

J Neurosci Methods. 2017 Oct 1;290:57-68. doi: 10.1016/j.jneumeth.2017.07.017. Epub 2017 Jul 22.

PMID:
28739164
48.

Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis.

Lam RW, Wajsbrot DB, Meier E, Pappadopulos E, Mackell JA, Boucher M.

J Psychopharmacol. 2017 Sep;31(9):1204-1214. doi: 10.1177/0269881117719261. Epub 2017 Jul 18.

PMID:
28718346
49.

Subcortical structural volumes in recently remitted first episode mania.

Arumugham SS, Torres IJ, Lang DJ, Su W, Lam RW, Honer WG, Yatham LN.

J Affect Disord. 2017 Nov;222:23-27. doi: 10.1016/j.jad.2017.06.051. Epub 2017 Jun 24.

PMID:
28667890
50.

The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.

McIntyre RS, Lee Y, Zhou AJ, Rosenblat JD, Peters EM, Lam RW, Kennedy SH, Rong C, Jerrell JM.

J Clin Psychopharmacol. 2017 Aug;37(4):412-418. doi: 10.1097/JCP.0000000000000723. Review.

PMID:
28590365

Supplemental Content

Support Center